303 related articles for article (PubMed ID: 32229700)
21. Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor Progression.
Fahrmann JF; Wasylishen AR; Pieterman CRC; Irajizad E; Vykoukal J; Wu R; Dennison JB; Peterson CB; Zhao H; Do KA; Halperin DM; Agarwal SK; Blau JE; Jha S; Rivero JD; Nilubol N; Walter MF; Welch JM; Weinstein LS; Vriens MR; van Leeuwaarde RS; van Treijen MJC; Valk GD; Perrier ND; Hanash SM; Katayama H
J Clin Endocrinol Metab; 2023 Nov; 108(12):3260-3271. PubMed ID: 37307230
[TBL] [Abstract][Full Text] [Related]
22. A Blood-based Polyamine Signature Associated With MEN1 Duodenopancreatic Neuroendocrine Tumor Progression.
Fahrmann JF; Wasylishen AR; Pieterman CRC; Irajizad E; Vykoukal J; Murage E; Wu R; Dennison JB; Krishna H; Peterson CB; Lozano G; Zhao H; Do KA; Halperin DM; Agarwal SK; Blau JE; Del Rivero J; Nilubol N; Walter MF; Welch JM; Weinstein LS; Vriens MR; van Leeuwaarde RS; van Treijen MJC; Valk GD; Perrier ND; Hanash SM
J Clin Endocrinol Metab; 2021 Nov; 106(12):e4969-e4980. PubMed ID: 34318891
[TBL] [Abstract][Full Text] [Related]
23. Status of Surveillance and Nonsurgical Therapy for Small Nonfunctioning Pancreatic Neuroendocrine Tumors.
van Beek DJ; Verschuur AVD; Brosens LAA; Valk GD; Pieterman CRC; Vriens MR
Surg Oncol Clin N Am; 2023 Apr; 32(2):343-371. PubMed ID: 36925190
[TBL] [Abstract][Full Text] [Related]
24. Expression of p27
Conemans EB; Raicu-Ionita GM; Pieterman CRC; Dreijerink KMA; Dekkers OM; Hermus AR; de Herder WW; Drent ML; van der Horst-Schrivers ANA; Havekes B; Bisschop PH; Offerhaus GJ; Borel Rinkes IHM; Valk GD; Timmers HTM; Vriens MR
J Endocrinol Invest; 2018 Jun; 41(6):655-661. PubMed ID: 29134609
[TBL] [Abstract][Full Text] [Related]
25. Surveillance strategy for small asymptomatic non-functional pancreatic neuroendocrine tumors - a systematic review and meta-analysis.
Sallinen V; Le Large TY; Galeev S; Kovalenko Z; Tieftrunk E; Araujo R; Ceyhan GO; Gaujoux S
HPB (Oxford); 2017 Apr; 19(4):310-320. PubMed ID: 28254159
[TBL] [Abstract][Full Text] [Related]
26. Management of pancreatic neuroendocrine tumors in patients with MEN 1.
Sadowski SM; Triponez F
Gland Surg; 2015 Feb; 4(1):63-8. PubMed ID: 25713781
[TBL] [Abstract][Full Text] [Related]
27. Nonfunctional pancreatic endocrine tumor in the peripancreatic region in a Chinese patient with multiple endocrine neoplasia type 1.
Wang BP; Tian WJ; Zhang J; Jiang CX; Qu HQ; Zhu M
J Int Med Res; 2018 Feb; 46(2):908-915. PubMed ID: 29239255
[TBL] [Abstract][Full Text] [Related]
28. HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: MEN1-related pancreatic NETs: identification of unmet clinical needs and future directives.
Pieterman CRC; Sadowski SM; Maxwell JE; Katz MHG; Lines KE; Heaphy CM; Tirosh A; Blau JE; Perrier ND; Lewis MA; Metzcar JP; Halperin DM; Thakker RV; Valk GD
Endocr Relat Cancer; 2020 Aug; 27(8):T9-T25. PubMed ID: 32069215
[TBL] [Abstract][Full Text] [Related]
29. PROGNOSTIC FACTORS FOR SURVIVAL OF MEN1 PATIENTS WITH DUODENOPANCREATIC TUMORS METASTATIC TO THE LIVER: RESULTS FROM THE DMSG.
Conemans EB; Nell S; Pieterman CRC; de Herder WW; Dekkers OM; Hermus AR; van der Horst-Schrivers AN; Bisschop PH; Havekes B; Drent ML; Vriens MR; Valk GD
Endocr Pract; 2017 Jun; 23(6):641-648. PubMed ID: 28225311
[TBL] [Abstract][Full Text] [Related]
30. Reliability and Agreement of Radiological and Pathological Tumor Size in Patients with Multiple Endocrine Neoplasia Type 1-Related Pancreatic Neuroendocrine Tumors: Results from a Population-Based Cohort.
van Beek DJ; Verkooijen HM; Nell S; Bonsing BA; van Eijck CH; van Goor H; Hoogwater FJH; Nieveen van Dijkum EJM; Kazemier G; Dejong CHC; Brosens LAA; Wessels FJ; Borel Rinkes IHM; Valk GD; Vriens MR
Neuroendocrinology; 2021; 111(8):705-717. PubMed ID: 32721974
[TBL] [Abstract][Full Text] [Related]
31. Fate of Surgical Patients with Small Nonfunctioning Pancreatic Neuroendocrine Tumors: An International Study Using Multi-Institutional Registries.
Han IW; Park J; Park EY; Yoon SJ; Jin G; Hwang DW; Jiang K; Kwon W; Xu X; Heo JS; Fu DL; Lee WJ; Bai X; Yoon YS; Yang YM; Ahn KS; Yuan C; Lee HK; Sun B; Park EK; Lee SE; Kang S; Lou W; Park SJ
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205787
[TBL] [Abstract][Full Text] [Related]
32. Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1.
Kouvaraki MA; Shapiro SE; Cote GJ; Lee JE; Yao JC; Waguespack SG; Gagel RF; Evans DB; Perrier ND
World J Surg; 2006 May; 30(5):643-53. PubMed ID: 16680581
[TBL] [Abstract][Full Text] [Related]
33. Current and emerging therapies for PNETs in patients with or without MEN1.
Frost M; Lines KE; Thakker RV
Nat Rev Endocrinol; 2018 Apr; 14(4):216-227. PubMed ID: 29449689
[TBL] [Abstract][Full Text] [Related]
34. Systematic Review and Metaanalysis of Lymph Node Metastases of Resected Pancreatic Neuroendocrine Tumors.
Tanaka M; Heckler M; Mihaljevic AL; Probst P; Klaiber U; Heger U; Schimmack S; Büchler MW; Hackert T
Ann Surg Oncol; 2021 Mar; 28(3):1614-1624. PubMed ID: 32720049
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of (68)Ga-DOTA-TOC PET/CT for the detection of duodenopancreatic neuroendocrine tumors in patients with MEN1.
Morgat C; Vélayoudom-Céphise FL; Schwartz P; Guyot M; Gaye D; Vimont D; Schulz J; Mazère J; Nunes ML; Smith D; Hindié E; Fernandez P; Tabarin A
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1258-66. PubMed ID: 26819103
[TBL] [Abstract][Full Text] [Related]
36. Care for patients with multiple endocrine neoplasia type 1: the current evidence base.
Pieterman CR; Vriens MR; Dreijerink KM; van der Luijt RB; Valk GD
Fam Cancer; 2011 Mar; 10(1):157-71. PubMed ID: 21061174
[TBL] [Abstract][Full Text] [Related]
37. Distinct DNA Methylation Signatures in Neuroendocrine Tumors Specific for Primary Site and Inherited Predisposition.
Tirosh A; Killian JK; Petersen D; Zhu YJ; Walker RL; Blau JE; Nilubol N; Patel D; Agarwal SK; Weinstein LS; Meltzer P; Kebebew E
J Clin Endocrinol Metab; 2020 Oct; 105(10):3285-94. PubMed ID: 32706863
[TBL] [Abstract][Full Text] [Related]
38. The current strategy for managing pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1.
Niina Y; Fujimori N; Nakamura T; Igarashi H; Oono T; Nakamura K; Kato M; Jensen RT; Ito T; Takayanagi R
Gut Liver; 2012 Jul; 6(3):287-94. PubMed ID: 22844555
[TBL] [Abstract][Full Text] [Related]
39. First surgery for pancreatic neuroendocrine tumours in a patient with MEN1: enucleation versus disease-modifying surgery.
Harper S; Harrison B
Clin Endocrinol (Oxf); 2015 Nov; 83(5):618-21. PubMed ID: 25807996
[TBL] [Abstract][Full Text] [Related]
40. Genes involved in angiogenesis and mTOR pathways are frequently mutated in Asian patients with pancreatic neuroendocrine tumors.
Chou WC; Lin PH; Yeh YC; Shyr YM; Fang WL; Wang SE; Liu CY; Chang PM; Chen MH; Hung YP; Li CP; Chao Y; Chen MH
Int J Biol Sci; 2016; 12(12):1523-1532. PubMed ID: 27994516
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]